JMJohn F. Markham

John F. Markham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John F. Markham has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Stochastically Timed Competition Between Division and Differentiation Fates Regulates the Transition From B Lymphoblast to Plasma Cell

    by Jie H. S. Zhou, John F. Markham, Ken R. Duffy, Philip D. Hodgkin

    In response to external stimuli, naïve B cells proliferate and take on a range of fates important for immunity. How their fate is determined is a topic of much recent research, with candidates including asymmetric cell division, lineage priming, stochastic assignment, and microenvironment instruction. Here we manipulate the generation of plasmablasts from B lymphocytes in vitro by varying CD40 stimulation strength to determine its influence on potential sources of fate control. Using long-term live cell imaging, we directly measure times to differentiate, divide, and die of hundreds of pairs of sibling cells. These data reveal that while the allocation of fates is significantly altered by signal strength, the proportion of siblings identified with asymmetric fates is unchanged. In contrast, we find that plasmablast generation is enhanced by slowing times to divide, which is consistent with a hypothesis of competing timed stochastic fate outcomes. We conclude that this mechanistically simple source of alternative fate regulation is important, and that useful quantitative models of signal integration can be developed based on its principles.


  • Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing

    by Georgina L Ryland, Kate Jones, Melody Chin, John Markham, Elle Aydogan, Yamuna Kankanige, Marisa Caruso, Jerick Guinto, Michael Dickinson, H Miles Prince, et al.

    Aims: Multiple myeloma is a genomically complex haematological malignancy with many genomic alterations recognised as important in diagnosis, prognosis and therapeutic decision making. Here, we provide a summary of genomic findings identified through routine diagnostic next-generation sequencing at our centre. Methods: A cohort of 86 patients with multiple myeloma underwent diagnostic sequencing using a custom hybridisation-based panel targeting 104 genes. Sequence variants, genome-wide copy number changes and structural rearrangements were detected using an inhouse-developed bioinformatics pipeline. Results: At least one mutation was found in 69 (80%) patients. Frequently mutated genes included TP53 (36%), KRAS (22.1%), NRAS (15.1%), FAM46C/DIS3 (8.1%) and TET2/FGFR3 (5.8%), including multiple mutations not previously described in myeloma. Importantly we observed TP53 mutations in the absence of a 17 p deletion in 8% of the cohort, highlighting the need for sequencing-based assessment in addition to cytogenetics to identify these high-risk patients. Multiple novel copy number changes and immunoglobulin heavy chain translocations are also discussed. Conclusions: Our results demonstrate that many clinically relevant genomic findings remain in multiple myeloma which have not yet been identified through large-scale sequencing efforts, and provide important mechanistic insights into plasma cell pathobiology.


  • Open Access

    Genome analysis of Mycoplasma synoviae strain MS-H, the most common M. synoviae strain with a worldwide distribution

    by Ling Zhu, Muhammad A. Shahid, John Markham, Glenn F. Browning, Amir H. Noormohammadi, Marc S. Marenda

    The bacterial pathogen Mycoplasma synoviae can cause subclinical respiratory disease, synovitis, airsacculitis and reproductive tract disease in poultry and is a major cause of economic loss worldwide. The M. synoviae strain MS-H was developed by chemical mutagenesis of an Australian isolate and has been used as a live attenuated vaccine in many countries over the past two decades. As a result it may now be the most prevalent strain of M. synoviae globally. Differentiation of the MS-H vaccine from local field strains is important for epidemiological investigations and is often required for registration of the vaccine. The complete genomic sequence of the MS-H strain was determined using a combination of Illumina and Nanopore methods and compared to WVU-1853, the M. synoviae type strain isolated in the USA 30 years before the parent strain of MS-H, and MS53, a more recent isolate from Brazil. The vaccine strain genome had a slightly larger number of pseudogenes than the two other strains and contained a unique 55 kb chromosomal inversion partially affecting a putative genomic island. Variations in gene content were also noted, including a deoxyribose-phosphate aldolase (deoC) fragment and an ATP-dependent DNA helicase gene found only in MS-H. Some of these sequences may have been acquired horizontally from other avian mycoplasma species. MS-H was somewhat more similar to WVU-1853 than to MS53. The genome sequence of MS-H will enable identification of vaccine-specific genetic markers for use as diagnostic and epidemiological tools to better control M. synoviae.


  • Open Access

    ASXL1 c.1934dup;p.Gly646Trpfs*12—a true somatic alteration requiring a new approach

    by Costas K. Yannakou, Kate Jones, Michelle McBean, Ella R. Thompson, Georgina L. Ryland, Ken Doig, John Markham, David Westerman, Piers Blombery


  • Detection of clinically relevant early genomic lesions in B‐cell malignancies from circulating tumour DNA using a single hybridisation‐based next generation sequencing assay

    by Piers A. Blombery, Georgina L. Ryland, John Markham, Jerick Guinto, Meaghan Wall, Michelle McBean, Kate Jones, Ella R. Thompson, Daniel L. Cameron, Anthony T. Papenfuss, et al.


  • Open Access

    Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma

    by P. Blombery, E. R. Thompson, K. Jones, G. M. Arnau, S. Lade, J. F. Markham, J. Li, A. Deva, R. W. Johnstone, A. Khot, et al.

    Publisher's Disclaimer. E-publishing ahead of print is increasingly important for the rapid dissemination of science. Haematologica is, therefore, E-publishing PDF files of an early version of manuscripts that have completed a regular peer review and have been accepted for publication. E


  • Ranking cell tracking systems without manual validation

    by Andrey Kan, John Markham, Rajib Chakravorty, James Bailey, Christopher Leckie


  • Evaluating Spectral Unmixing Quality in the Absence of Reference Objects for Time Lapse Fluorescence Microscopy

    by Liyan Liu, Andrey Kan, Jie H.S. Zhou, John F. Markham, Philip D. Hodgkin, Christopher Leckie

    Time lapse fluorescence microscopy can be used to monitor the behaviour of individual cells over time, but the imaging results can be affected by the inherent problem of overlapping emission spectra, commonly referred to as cross-talk. Various spectral unmixing methods have been adopted to solve this problem, thereby estimating the original signal from the observed mixture. The methods for evaluating the quality of spectral unmixing are usually based on the reference objects: a set of pixels where one of the signals is present while another is absent. However, reference objects are not always readily available, particularly in experiments that involve multi-colour fluorescence reporters. Moreover, there is little discussion about how we select training data to estimate the cross-talk coefficients of spectral unmixing methods. Our purpose is to address the challenge of missing reference objects by proposing a new quality evaluation approach, and to consider different strategies of training data selection. To this end, we develop a correlation-based quality measure that employs spatiotemporal information, and compare spectral unmixing results obtained using different training strategies.


  • Open Access

    Predicting expression: the complementary power of histone modification and transcription factor binding data

    by David M Budden, Daniel G Hurley, Joseph Cursons, John F Markham, Melissa J Davis, Edmund J Crampin

    Transcription factors (TFs) and histone modifications (HMs) play critical roles in gene expression by regulating mRNA transcription. Modelling frameworks have been developed to integrate high-throughput omics data, with the aim of elucidating the regulatory logic that results from the interactions of DNA, TFs and HMs. These models have yielded an unexpected and poorly understood result: that TFs and HMs are statistically redundant in explaining mRNA transcript abundance at a genome-wide level. We constructed predictive models of gene expression by integrating RNA-sequencing, TF and HM chromatin immunoprecipitation sequencing and DNase I hypersensitivity data for two mammalian cell types. All models identified genome-wide statistical redundancy both within and between TFs and HMs, as previously reported. To investigate potential explanations, groups of genes were constructed for ontology-classified biological processes. Predictive models were constructed for each process to explore the distribution of statistical redundancy. We found significant variation in the predictive capacity of TFs and HMs across these processes and demonstrated the predictive power of HMs to be inversely proportional to process enrichment for housekeeping genes. It is well established that the roles played by TFs and HMs are not functionally redundant. Instead, we attribute the statistical redundancy reported in this and previous genome-wide modelling studies to the heterogeneous distribution of HMs across chromatin domains. Furthermore, we conclude that statistical redundancy between individual TFs can be readily explained by nucleosome-mediated cooperative binding. This could possibly help the cell confer regulatory robustness by rejecting signalling noise and allowing control via multiple pathways.


  • A lineage of diploid platelet-forming cells precedes polyploid megakaryocyte formation in the mouse embryo

    by Kathryn S. Potts, Tobias J. Sargeant, John F. Markham, Wei Shi, Christine Biben, Emma C. Josefsson, Lachlan W. Whitehead, Kelly L. Rogers, Anna Liakhovitskaia, Gordon K. Smyth, et al.

    In this study, we test the assumption that the hematopoietic progenitor/colony-forming cells of the embryonic yolk sac (YS), which are endowed with megakaryocytic potential, differentiate into the first platelet-forming cells in vivo. We demonstrate that from embryonic day (E) 8.5 all megakaryocyte (MK) colony-forming cells belong to the conventional hematopoietic progenitor cell (HPC) compartment. Although these cells are indeed capable of generating polyploid MKs, they are not the source of the first platelet-forming cells. We show that proplatelet formation first occurs in a unique and previously unrecognized lineage of diploid platelet-forming cells, which develop within the YS in parallel to HPCs but can be specified in the E8.5 Runx1-null embryo despite the absence of the progenitor cell lineage. Key Points The first embryonic platelets are produced by a unique lineage of diploid cells not polyploid MKs. Diploid platelet-forming cells are produced in the early mouse embryo via a progenitor cell–independent pathway.